×
About 11,160 results

ALLMedicine™ Herpes Zoster Center

Research & Reviews  4,367 results

Emergence of varicella-zoster virus resistance to acyclovir: epidemiology, prevention, ...
https://doi.org/10.1080/14787210.2021.1917992
Expert Review of Anti-infective Therapy; Shiraki K, Takemoto M et. al.

Apr 15th, 2021 - Acyclovir has led to the development of successful systemic therapy for herpes simplex virus and varicella-zoster virus (VZV) infection, and the use of valacyclovir and famciclovir has improved treatment. Additionally, the use of a helicase-primas...

Pilot Analyses of Interferon Subtype Expression Profiles in Patients with Herpes Zoster...
https://doi.org/10.1089/vim.2020.0295
Viral Immunology; Chen YC, Figliozzi RW et. al.

Apr 15th, 2021 - Postherpetic neuralgia (PHN) is a painful neuropathic complication resulting from herpes zoster (HZ). The pain manifests in peripheral nerves infected by herpesviruses, mostly from reactivation of latent varicella zoster virus. Mechanistic descrip...

Arsenic trioxide therapy predisposes to herpes zoster reactivation despite minimally my...
https://doi.org/10.1016/j.leukres.2021.106569
Leukemia Research; Glass JL, Derkach A et. al.

Apr 15th, 2021 - Acute Promyelocytic Leukemia (APL) is a unique subtype of acute myeloid leukemia that is highly responsive to minimally myelosuppressive therapy with all-trans retinoic acid (ATRA) and arsenic trioxide (ATO). We and others have observed a higher t...

Early examination of real-world uptake and second-dose completion of recombinant zoster...
https://doi.org/10.1080/21645515.2021.1879579
Human Vaccines & Immunotherapeutics; Patterson BJ, Chen CC et. al.

Apr 14th, 2021 - Shingrix (Recombinant zoster vaccine, RZV) was approved in October 2017 in the United States (US) for the prevention of herpes zoster in adults aged 50 years and older. The vaccine is administered in two doses, with the second dose administration ...

Herpes Zoster (Shingles) Patient-Centered Wound Outcomes: A Literature Review.
https://doi.org/10.1097/01.ASW.0000741896.24399.43
Advances in Skin & Wound Care;

Apr 14th, 2021 - Herpes Zoster (Shingles) Patient-Centered Wound Outcomes: A Literature Review.|2021||

see more →

Guidelines  131 results

Bullous Disseminated Herpes Zoster: An Atypical Presentation
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7437097/
Cureus Jethwa T

Jul 19th, 2020 - Herpes zoster is an infection resulting from the reactivation of dormant varicella zoster virus (VZV) in a posterior dorsal root ganglion. It affects 50% of immunocompromised patients and, when the viral infection persists, it can lead to a proces...

Shingles - Genetics Home Reference - NIH
https://ghr.nlm.nih.gov/condition/shingles

Oct 28th, 2019 - Shingles (also known as herpes zoster) results from infection by the varicella zoster virus. This common virus causes chickenpox (also known as varicella), which is characterized by itchy spots on the skin that cover the whole body and usually oc...

Shingles | Resources and References | Herpes Zoster | CDC<
https://www.cdc.gov/shingles/resources-refs.html

Jul 1st, 2019 - Shingles resources and references include Shingrix and Zostavax vaccination recommendations, as well as disease- and vaccine-related resources and articles.

Shingles | Surveillance, Trends, Deaths | Herpes Zoster | CDC
https://www.cdc.gov/shingles/surveillance.html

Jun 30th, 2019 - Learn more about shingles surveillance, including shingles hospitalizations, trends, and vaccination rates

Shingles | Laboratory Testing for VZV | Herpes Zoster | CDC
https://www.cdc.gov/shingles/lab-testing/index.html

Jun 30th, 2019 - Learn about varicella zoster virus (VZV) laboratory testing and about the CDC National VDZ Laboratory.

see more →

Drugs  657 results see all →

Clinicaltrials.gov  5,323 results

Emergence of varicella-zoster virus resistance to acyclovir: epidemiology, prevention, ...
https://doi.org/10.1080/14787210.2021.1917992
Expert Review of Anti-infective Therapy; Shiraki K, Takemoto M et. al.

Apr 15th, 2021 - Acyclovir has led to the development of successful systemic therapy for herpes simplex virus and varicella-zoster virus (VZV) infection, and the use of valacyclovir and famciclovir has improved treatment. Additionally, the use of a helicase-primas...

Pilot Analyses of Interferon Subtype Expression Profiles in Patients with Herpes Zoster...
https://doi.org/10.1089/vim.2020.0295
Viral Immunology; Chen YC, Figliozzi RW et. al.

Apr 15th, 2021 - Postherpetic neuralgia (PHN) is a painful neuropathic complication resulting from herpes zoster (HZ). The pain manifests in peripheral nerves infected by herpesviruses, mostly from reactivation of latent varicella zoster virus. Mechanistic descrip...

Arsenic trioxide therapy predisposes to herpes zoster reactivation despite minimally my...
https://doi.org/10.1016/j.leukres.2021.106569
Leukemia Research; Glass JL, Derkach A et. al.

Apr 15th, 2021 - Acute Promyelocytic Leukemia (APL) is a unique subtype of acute myeloid leukemia that is highly responsive to minimally myelosuppressive therapy with all-trans retinoic acid (ATRA) and arsenic trioxide (ATO). We and others have observed a higher t...

Early examination of real-world uptake and second-dose completion of recombinant zoster...
https://doi.org/10.1080/21645515.2021.1879579
Human Vaccines & Immunotherapeutics; Patterson BJ, Chen CC et. al.

Apr 14th, 2021 - Shingrix (Recombinant zoster vaccine, RZV) was approved in October 2017 in the United States (US) for the prevention of herpes zoster in adults aged 50 years and older. The vaccine is administered in two doses, with the second dose administration ...

Herpes Zoster (Shingles) Patient-Centered Wound Outcomes: A Literature Review.
https://doi.org/10.1097/01.ASW.0000741896.24399.43
Advances in Skin & Wound Care;

Apr 14th, 2021 - Herpes Zoster (Shingles) Patient-Centered Wound Outcomes: A Literature Review.|2021||

see more →

News  673 results

Acute Non-PHN Complications of Herpes Zoster
https://www.medscape.com/viewarticle/941590

Nov 24th, 2020 - Acute complications of herpes zoster (HZ) other than post-herpetic neuralgia (PHN) are relatively common, a new study suggests. Researchers conducted a cohort study of unvaccinated immunocompetent adults with incident HZ (n=178,964) and matched to...

A Man With Skin Plaques Has Severe Pain After Eating
https://reference.medscape.com/viewarticle/884106_6

Sep 24th, 2020 - Question 1 of 2 Which of the following laboratory tests has the highest sensitivity, provides rapid results, and can be used to monitor treatment response when collected serially in patients with suspected herpes zoster? Your Peers Chose: VZV IgG ...

Fast Five Quiz: Arthritis
https://reference.medscape.com/viewarticle/934417_6

Jul 27th, 2020 - Answer 5/5 Which of the following is recommended regarding the pharmacologic treatment of RA, according to 2015 guidelines from the ACR? Your peers chose: For patients with established RA who have moderate disease activity and have never taken a d...

Bullous Disseminated Herpes Zoster: An Atypical Presentation
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7437097/
Cureus Jethwa T

Jul 19th, 2020 - Herpes zoster is an infection resulting from the reactivation of dormant varicella zoster virus (VZV) in a posterior dorsal root ganglion. It affects 50% of immunocompromised patients and, when the viral infection persists, it can lead to a proces...

The Considerable Toll of Herpes Zoster Ophthalmicus Is Also Avoidable
https://www.medscape.com/viewarticle/932101

Jun 16th, 2020 - Many clinicians acknowledge that herpes zoster (or shingles) is not something they would wish to have, but they also seem to believe it just comes and goes. This could explain the rather low rate of vaccination since the zoster vaccine live (Zosta...

see more →

Patient Education  9 results see all →